Welcome to Zentiva Italy WHO WE ARE EQUIVALENTS PRODUCTS NEWS SERVICES INITIATIVES TO KNOW MORE PARTNERSHIP CONTACTS < > Events And News + EVENTS | Zentiva "takes the field" for a good cause in the 30th edition of the "Partita del Cuore", alongside the Italian Singers National Team + EVENTS | Zentiva continues its expansion in the oncology sector with the launch of ALYMSYS® (Bevacizumab) in 21 countries across Europe FACEBOOK TWITTER INSTAGRAM INITIATIVES FIND THE PHARMACY NEWSLETTER Copyright © 2021 Zentiva Italia srl All rights reserved. Zentiva Italia Srl - Subject to the direction and coordination of Al Sirona (Luxembourg) Acquisition S.à rl - Registered office: Viale Luigi Bodio, 37 / B - 20158 - Milan - Administrative office: Via P. Paleocapa, 7 - 20121 - Milan - +39 0238598801 Share Capital € 1,000,000.00 fully paid-up - REA 1463705 - Business Register of Milan / CF / VAT No. 11388870153 - zentivaitalia_srl@pec.it Sitemap - Terms of use - GDPR - Cookie Policy - Site intended for Italian users - Last update: 25/11/2021

France Home Who are we Our engagements Our Medicines Your health Jobs Zentiva Pro Contact Our history Site map | Legal notices | GDPR A generic drug is a specialty which has the same qualitative and quantitative composition in active ingredients and the same pharmaceutical form as the reference drug. Its bioequivalence with the reference specialty has been demonstrated by appropriate bioavailability studies. Source: Public Health Code: art. L5121.1 © 2020 - Zentiva France - Site intended for residents of France - All rights reserved - GP code: 7100000727 - 01/2020 - Zentiva France SAS - 407 710 474 RCS Paris - 35 rue de Val de Marne, 75013 Paris | Legal notices | Cookies Policy | Last updated: November 25, 2021 Change cookies settings